Recall of Medline Convenience Kits Due to Unapproved Design Changes

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Medline Industries, LP is recalling certain convenience kits containing 10mL polycarbonate colored syringes because of unapproved design changes, affecting 270,311 units distributed nationwide and internationally.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on May 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.

What Happened

Medline Industries, LP is recalling certain convenience kits due to unapproved design changes to the products outside of the 510(k) clearance.

Which Products Are Affected

The affected products are Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes, including the following: BASIC CL PACK-LF (DYNJ87052), BASIC PACK (DYNJ83976), BASIC SET UP PACK (DYNJ80700), CORONARY ANGIOGRAPHY PACK (N) (DYNJ42136B), CSTM ANGIO KIT - S VASC1109 (VASC1109), CV PACK (DYNJ46301C), DR F PACK (DYNJ41253B), ENSEMBLE HEMORROIDES (DYNJ56311A), G TAVR PACK (DYNJ61006), IR MINOR PACK (DYNJ44139C), MAJOR PLUS PACK (DYNJ905160N), MAXIMUM BARRIER BUNDLE PACK (DYNJ35216C), PCI PACK TBRHSC-LF (DYNJ41941D), PERC PACK-LF (DYNJ0774759P), PERIPHERAL ANGIOGRAPHY PK (DYNJ42094B), PROCEDURE PACK (DYNJ55063B), PTCA PACK (DYNJ55359B), ROBOTIC PACK (DYNJ908706C), SPECIAL PROCEDURES TRAY (DYNJ41174A), SYRINGE WIRE KIT SANFORD (SAMPC0644), WPH EP PACK (DYNJ62745), and X-RAY PACK (DYNJ44295G). The total quantity affected is 270,311 units. Specific lots and UDI-DI codes are provided in the source data, with distribution in the United States nationwide and countries including Canada, Panama, and Barbados.

What You Should Do

Consumers should follow the firm's initial notification via letter and contact Medline Industries, LP at their address: 3 Lakes Dr, Northfield, IL 60093-2753, for information on returns or refunds related to this recall.

Why This Matters

This recall involves medical devices with unapproved changes, which could potentially affect product safety and efficacy, impacting healthcare providers and patients relying on these kits for procedures.

Source

Attribution: FDA Recall Number Z-1883-2026. For more information, refer to the FDA's official recall database.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Medline Industries, LP is recalling certain convenience kits containing 10mL polycarbonate colored syringes because of unapproved design changes, affecting 270,311 units distributed nationwide and internationally.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.